JP2019516665A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516665A5
JP2019516665A5 JP2018546587A JP2018546587A JP2019516665A5 JP 2019516665 A5 JP2019516665 A5 JP 2019516665A5 JP 2018546587 A JP2018546587 A JP 2018546587A JP 2018546587 A JP2018546587 A JP 2018546587A JP 2019516665 A5 JP2019516665 A5 JP 2019516665A5
Authority
JP
Japan
Prior art keywords
polypeptide
terminal
mhc
multimeric
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018546587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/020276 external-priority patent/WO2017151818A2/en
Publication of JP2019516665A publication Critical patent/JP2019516665A/ja
Publication of JP2019516665A5 publication Critical patent/JP2019516665A5/ja
Pending legal-status Critical Current

Links

JP2018546587A 2016-03-02 2017-03-01 T細胞調節多量体ポリペプチド及びその使用方法 Pending JP2019516665A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662302654P 2016-03-02 2016-03-02
US62/302,654 2016-03-02
PCT/US2017/020276 WO2017151818A2 (en) 2016-03-02 2017-03-01 T-cell modulatory multimeric polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2019516665A JP2019516665A (ja) 2019-06-20
JP2019516665A5 true JP2019516665A5 (https=) 2020-04-09

Family

ID=59743228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018546587A Pending JP2019516665A (ja) 2016-03-02 2017-03-01 T細胞調節多量体ポリペプチド及びその使用方法

Country Status (9)

Country Link
US (2) US20190062400A1 (https=)
EP (1) EP3423108A4 (https=)
JP (1) JP2019516665A (https=)
KR (1) KR20180132663A (https=)
CN (1) CN109311945A (https=)
AU (1) AU2017226269B2 (https=)
CA (1) CA3014458A1 (https=)
IL (1) IL261401A (https=)
WO (1) WO2017151818A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2894511C (en) 2012-12-11 2021-12-07 Albert Einstein College Of Medicine Of Yeshiva University Methods for high throughput receptor:ligand identification
CN121159719A (zh) 2015-04-17 2025-12-19 高山免疫科学股份有限公司 具有可调的亲和力的免疫调节蛋白
US10273281B2 (en) 2015-11-02 2019-04-30 Five Prime Therapeutics, Inc. CD80 extracellular domain polypeptides and their use in cancer treatment
WO2017181152A2 (en) 2016-04-15 2017-10-19 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
CN109689096A (zh) 2016-05-18 2019-04-26 阿尔伯特爱因斯坦医学院公司 变体pd-l1多肽、t细胞调节性多聚体多肽及其使用方法
WO2017201210A1 (en) 2016-05-18 2017-11-23 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
ES2973548T3 (es) 2016-12-22 2024-06-20 Cue Biopharma Inc Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso
EP3565829A4 (en) 2017-01-09 2021-01-27 Cue Biopharma, Inc. T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF
US20200010528A1 (en) 2017-03-15 2020-01-09 Cue Biopharma, Inc. Methods for modulating an immune response
SG11201907769XA (en) 2017-03-16 2019-09-27 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
KR20190139216A (ko) 2017-04-28 2019-12-17 파이브 프라임 테라퓨틱스, 인크. Cd80 세포외 도메인 폴리펩티드를 이용한 치료 방법
JP2020534352A (ja) * 2017-09-07 2020-11-26 キュー バイオファーマ,インコーポレーテッド コンジュゲーション部位を有するt細胞調節多量体ポリペプチド及びその使用方法
EP3678677A4 (en) * 2017-09-07 2021-06-16 Cue Biopharma, Inc. Antigen-presenting polypeptides and methods of use thereof
CN111886241A (zh) 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
EP3897690A4 (en) * 2018-12-19 2022-09-28 Cue Biopharma, Inc. T LYMPHOCYTE MODULATOR MULTIMERIC POLYPEPTIDES HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
US12589132B2 (en) 2019-02-22 2026-03-31 Five Prime Therapeutics, Inc. CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors
WO2020181272A1 (en) * 2019-03-06 2020-09-10 Cue Biopharma, Inc. Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof
KR20220015382A (ko) * 2019-05-29 2022-02-08 큐 바이오파마, 인크. 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법
CA3146591A1 (en) * 2019-09-20 2021-03-25 Ronald D. Seidel Iii T-cell modulatory polypeptides and methods of use thereof
DK4034170T3 (da) 2019-10-23 2026-03-30 Cue Biopharma Inc Tgf-beta-polypeptider
US20230126784A1 (en) * 2020-03-06 2023-04-27 Albert Einstein College Of Medicine A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific cytotoxic lymphocytes to enable the subsequent in vivo modulation of their functional activity
EP4118105A2 (en) * 2020-03-09 2023-01-18 Pfizer Inc. Cd80-fc fusion protein and uses thereof
WO2021231376A2 (en) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
US20230218731A1 (en) * 2020-05-26 2023-07-13 Cue Biopharma, Inc. Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
WO2021242935A1 (en) * 2020-05-26 2021-12-02 Cue Biopharma, Inc. Antigen presenting polypeptide complexes and methods of use thereof
IL299834A (en) * 2020-07-14 2023-03-01 Cue Biopharma Inc with binding sites and methods for using them T - cellular modulatory polypeptides
WO2022056014A1 (en) 2020-09-09 2022-03-17 Cue Biopharma, Inc. Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof
CA3216273A1 (en) * 2021-04-21 2022-10-27 Ronald D. SEIDEL III Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof
WO2022251552A2 (en) * 2021-05-26 2022-12-01 Cue Biopharma, Inc. Antigen presenting polypeptide complexes and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202844B1 (pl) * 1998-04-07 2009-07-31 Corixa Corp Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
CN103796681B (zh) * 2011-06-30 2018-07-20 建新公司 T细胞活化的抑制剂
CN102898504B (zh) * 2012-10-23 2014-08-06 中国农业大学 抗氧化活性合成肽及其用途
WO2015195531A2 (en) * 2014-06-18 2015-12-23 Albert Einstein College Of Medicine, Inc. Syntac polypeptides and uses thereof

Similar Documents

Publication Publication Date Title
JP2019516665A5 (https=)
JP2019512222A5 (https=)
JP2019522465A5 (https=)
JP2019522466A5 (https=)
JP2022515330A5 (https=)
JP2020511949A5 (https=)
JP2022536581A5 (https=)
JP2021500855A5 (https=)
IL308851B2 (en) T-cell modulatory multimeric polypeptides and methods of use thereof
JP2017509335A5 (https=)
JP2019521643A5 (https=)
JP2017512063A5 (https=)
IL272085B (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
JP2020529841A5 (https=)
JP2018512856A5 (https=)
JP2016000731A5 (https=)
JP2015212284A5 (https=)
JP2015511637A5 (https=)
JP2020500525A5 (https=)
JP2020500015A5 (https=)
JP2017527272A5 (https=)
JP2018526970A5 (https=)
RU2015129640A (ru) Связанные дисульфидом мультивалентные многофункциональные белки, содержащие молекулы гкгс класса 1
JP2017519491A5 (https=)
PH12018502158B1 (en) T cell receptors